학술논문 – 부산대학교 도서관

학술논문

replay검색결과 돌아가기

search검색화면

Results from phase II, open-label study of anti-tumoral activity of first-line erlotinib in advanced/metastatic NSCLC patients with EGFR activating mutations, in Portugal: The MuTAR study

Document Type

article

Author

F. Barata; H. Queiroga; E. Teixeira; T. Almodovar; M. Soares; B. Parente; J.C. Mellidez; P. Alves; A. Antunes

Source

Pulmonology, Vol 27, Iss 2, Pp 175-177 (2021)

Subject

Diseases of the respiratory system
RC705-779

Language

English

ISSN

2531-0437

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Open Access (DOAJ) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일